| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −29.4× | −1.8× | |
| Price / Book | 8.1× | 2.1× | |
| Price / Sales | 1.3× | 4.0× | |
| Price / Free cash flow | −36.4× | −1.6× | |
| EV / EBITDA | −29.0× | −1.1× | |
| Earnings yield | −3.4% | −14.1% | |
| Free cash flow yield | −2.7% | −9.6% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,280.16 | −2.03% | $1.21T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $262.80 | −1.80% | $632.64B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.95 | −0.08% | $503.54B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $423.51 | −0.35% | $380.14B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.81 | −1.65% | $357.27B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.61 | −3.62% | $271.39B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $171.37 | −0.70% | $265.78B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $667.21 | −1.38% | $246.7B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $442.56 | −1.06% | $239.26B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.88 | −0.20% | $194.52B | 22.9× | 37.5% | +26.7% |
